First Step of The New Guidelines Consultation Announced
On October 25, 2023, the Patented Medicine ... Read More
Events
14
Nov2023
13
Nov2023
On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process ... Read More
02
Oct2023
On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended ... Read More
08
Sep2023
Mississauga, ON - September 11, 2023 – Canada’s leading biopharmaceutical pricing and reimbursement consultancy, PDCI Market Access (PDCI), ... Read More
05
Sep2023
On September 5, 2023, the pan-Canadian Pharmaceutical Alliance (pCPA) announced the appointment of Douglas Clark as its first ... Read More
03
Aug2023
PCPA Seeks Stakeholder Input On Its Proposed Process To Implement CADTH Time-Limited Recommendations
/ News, pCPA, What's New
The pan-Canadian Pharmaceutical Alliance (pCPA) introduced its proposed pCPA Temporary Access Process (pTAP) and invited stakeholders’ input on ... Read More
11
Jul2023
On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing ... Read More
11
Jul2023
CADTH Announces Changes to Reimbursement Reviews Process & Fee Schedule Update
/ CADTH, News, What's New
On June 5, 2023, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced a series of ... Read More